Nkarta, Inc.
For the period ended Mar 31, 2026. Filed May 12, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 12, 2026
NKTX$1.59-8.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Other Information
Item 5. Other Information.
During the quarter ended March 31, 2026, the following officers adopted a "Rule 10b5-1 trading arrangement" (as such terms are defined in Item 408(a) of Regulation S-K) as noted in the table below.
| Trading Arrangement | |||||
|---|---|---|---|---|---|
| Name and Title · Action · Date · Rule 10b5-1 · Non-Rule 10b5-1 · Total Shares to be Sold · Expiration Date | |||||
| Paul HastingsChief Executive Officer | Adoption | 1/22/2026 | X | 300,000 | 3/19/2027 |
| Nadir MahmoodPresident | Adoption | 2/18/2026 | X | 205,416 | 5/28/2027 |
| Shawn RoseChief Medical Officer and Head of Research & Development | Adoption | 2/12/2026 | X | 177,250 | 5/28/2027 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.